These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 34075358)

  • 21. SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal.
    Fernandes G; Paixão P; Brum L; Padrão T; Correia J; Albuquerque J; Pulido C; Nave M; Timóteo T; Rodrigues T; Costa F; Passos-Coelho JL
    Cureus; 2022 Feb; 14(2):e22428. PubMed ID: 35273890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study.
    Glennon K; Donnelly J; Knowles S; McAuliffe FM; O'Reilly A; Corcoran S; Walsh J; McMorrow R; Higgins T; Bolger L; Clinton S; O'Riordan S; Start A; Roche D; Bartels H; Malone C; McAuley K; McDermott A; Inzitari R; O'Donnell CPF; Malone F; Higgins S; De Gascun C; Doran P; Brennan DJ
    PLoS One; 2021; 16(9):e0253090. PubMed ID: 34543278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.
    Manolea C; Capitanescu A; Borș R; Rugescu I; Bechir M; Mehedintu C; Varlas V
    Hum Reprod Open; 2021; 2021(3):hoab028. PubMed ID: 34322605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study.
    Alcázar-Arroyo R; Portolés J; López-Sánchez P; Zalamea F; Furaz K; Méndez Á; Nieto L; Sánchez-Hernández R; Pizarro S; García A; Pereira M; Gallego-Valcárcel E; Llópez-Carratala R; Gadea-Gironés I; Martín R; Miranda B;
    Clin Kidney J; 2021 Jul; 14(7):1835-1844. PubMed ID: 34211708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
    Marra A; Generali D; Zagami P; Cervoni V; Gandini S; Venturini S; Morganti S; Passerini R; Orecchia R; Curigliano G
    Ann Oncol; 2021 Jan; 32(1):113-119. PubMed ID: 33098994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort.
    Molenaar NM; Rommel AS; de Witte L; Dolan SM; Lieb W; Ibroci E; Ohrn S; Lynch J; Capuano C; Stadlbauer D; Krammer F; Zapata LB; Brody RI; Pop VJ; Jessel RH; Sperling RS; Afzal O; Gigase F; Missall R; Janevic T; Stone J; Howell EA; Bergink V
    Paediatr Perinat Epidemiol; 2022 Jul; 36(4):466-475. PubMed ID: 34806193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anesthesiologists' and Intensive Care Providers' Exposure to COVID-19 Infection in a New York City Academic Center: A Prospective Cohort Study Assessing Symptoms and COVID-19 Antibody Testing.
    Morcuende M; Guglielminotti J; Landau R
    Anesth Analg; 2020 Sep; 131(3):669-676. PubMed ID: 32520728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 Cohort.
    Wiwe EF; Carlsson ER; Rasmussen CL; Rasmussen P; Ougaard R; Hansen SI; Schiøler T; Kristiansen S; Hansen YB; Hillig T
    J Appl Lab Med; 2022 May; 7(3):711-726. PubMed ID: 35134936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study.
    Baron RC; Risch L; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Bigler S; Egli K; Ferrara F; Bodmer T; Imperiali M; Heer S; Renz H; Flatz L; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch M
    Clin Chem Lab Med; 2020 Aug; 58(12):2131-2140. PubMed ID: 32866113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub-Saharan Africa: A prospective longitudinal study.
    Gebrecherkos T; Kiros YK; Challa F; Abdella S; Gebreegzabher A; Leta D; Desta A; Hailu A; Tasew G; Abdulkader M; Tessema M; Tollera G; Kifle T; Arefaine ZG; Schallig HH; Adams ER; Urban BC; de Wit TFR; Wolday D
    PLoS One; 2022; 17(3):e0263627. PubMed ID: 35320286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 IgG antibody responses in rt-PCR-positive cases: first report from India.
    Dash GC; Parai D; Choudhary HR; Peter A; Rout UK; Nanda RR; Kshatri JS; Kanungo S; Palo SK; Mandal N; Pati S; Bhattacharya D
    Access Microbiol; 2021; 3(10):000267. PubMed ID: 34816087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
    Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
    Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response.
    Petri M; Joyce D; Haag K; Fava A; Goldman DW; Zhong D; Xiao S; Milstone A; Magder LS
    Arthritis Care Res (Hoboken); 2023 Sep; 75(9):1878-1885. PubMed ID: 36714913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.